CervoMed CRVO Insider Ownership

NASDAQ CRVO

$1.35 -0.08 (-5.59%)

As of: Nov 10, 2026 · 2:27 PM EST

Insider Holdings by Owner

4.82Mn Shares

Joshua S Boger1.80Mn37.3%

Sylvie Gregoire1.50Mn31.1%

John J Alam1.50Mn31.1%

Matthew Winton15.00K0.3%

William Robert Elder12.50K0.3%

Other insiders (3)2.84K0.1%

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

24.47%

■0% pp QoQ

Shares Held by Insiders

3.31Mn

filed for Sep 2026

■0.00% QoQ

Shares Outstanding

13.53Mn

13,526,233 shares

Direct Holdings

1.51Mn

Indirect: 1.80Mn

Net Open-Market Trades

no open-market trades in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Open-Market Insider Trades

Bought Sold

Latest quarter —

Net over range —

Net-buying quarters —

Insider Ownership Summary

Updated Oct 24, 2026

Over the past 12 months, CervoMed insiders bought $3.46 million of stock on the open market (1.01Mn shares) and made no open-market sales.

By number of insiders, CervoMed saw 4 insiders buy on the open market over the past 12 months and none sell.
Among CRVO's insiders, Joshua S. Boger (Director and 10% owner) was the top open-market buyer in the past 12 months, with $3 million of stock purchased (955.41K shares) and the latest purchase on June 11, 2026.
Business Quant data shows CervoMed insiders holding 3.31Mn shares in total in their latest Form 4 filings, unchanged from 3.31Mn shares at the end of Q2 2026 and up 43.30% from 2.31Mn shares at the end of Q3 2025.
Indirect holdings, through trusts, partnerships, family members and other entities, make up 54.27% (1.8Mn shares) of CervoMed's insider total, with the other 45.73% (1.51Mn shares) held directly.
Holdings in CervoMed stock are reported by 6 insiders, the officers, directors and 10% owners who have filed a Form 4 in the past two years.
CRVO's largest insider holders by reported holdings are Joshua S. Boger (Director and 10% owner, 1.8Mn shares), John J. Alam (CEO & President, 1.48Mn shares) and Matthew Winton (Chief Commercial and Business, 15K shares).
Of the shares held by CRVO insiders, 54.27% belong to Joshua S. Boger.
Institutions held 12.92% of CervoMed's outstanding shares in their Q2 2026 13F filings, insiders about 24.47% based on their latest Form 4 filings, and other investors, including the public, the remaining 62.61%.
In the past year, 12 insiders of CervoMed submitted 29 Form 4 filings reporting trades, awards or other transactions.
These insider figures for CervoMed are based on Form 4 filings through October 23, 2026.

Form 4 Holdings

Insiders Holding CRVO

Insiders 8

Shares held 4.82Mn

Of outstanding 35.63%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Joshua S Boger	Director, TenPercentOwner	0	1,795,865	1,795,865	37.3%	15 Jun, 2026
2	Sylvie Gregoire	Director, TenPercentOwner	1,484,078	12,500	1,496,578	31.1%	19 Nov, 2025
3	John J Alam	Ceo President	1,484,078	12,500	1,496,578	31.1%	19 Nov, 2025
4	Matthew Winton	Chief Commercial And Business	15,000	0	15,000	0.3%	19 Nov, 2025
5	William Robert Elder	Cfo, Gc Secretary	12,500	0	12,500	0.3%	19 Nov, 2025
6	Robert Joseph Jr. Cobuzzi	President Ceo	1,743	0	1,743	0.0%	03 Feb, 2023
7	Jane H Hollingsworth	Director	898	0	898	0.0%	06 Sep, 2023
8	Diana M Lanchoney	Director	196	0	196	0.0%	30 Jun, 2023

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

313 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
22 Oct, 2026	Kelly Blackburn	Evp, Clinical Development	Acquired A	19,100	$0.00	$0	19,100	Direct
22 Oct, 2026	Rosch Mark De	Evp, Ra And Ga And Pgm	Acquired A	19,100	$0.00	$0	19,100	Direct
22 Oct, 2026	Matthew Winton	Chief Commercial And Business	Acquired A	19,100	$0.00	$0	19,100	Direct
11 Jun, 2026	Joshua S Boger	Director, TenPercentOwner	Acquired P	955,414	$3.14	$3.00Mn	1,795,865	Indirect
11 Jun, 2026	Joshua S Boger	Director, TenPercentOwner	Acquired P	955,414	—	—	955,414	Indirect
11 Jun, 2026	Joshua S Boger	Director, TenPercentOwner	Acquired P	955,414	—	—	955,414	Indirect
08 Jun, 2026	Joshua S Boger	Director, TenPercentOwner	Acquired A	8,150	$0.00	$0	8,150	Direct
08 Jun, 2026	Sylvie Gregoire	Director, TenPercentOwner	Acquired A	8,150	$0.00	$0	8,150	Direct
08 Jun, 2026	Jeffrey V. Poulton	Director	Acquired A	8,150	$0.00	$0	8,150	Direct
08 Jun, 2026	David Quigley	Director	Acquired A	8,150	$0.00	$0	8,150	Direct
08 Jun, 2026	Marwan Sabbagh	Director	Acquired A	8,150	$0.00	$0	8,150	Direct
08 Jun, 2026	Frank Zavrl	Director	Acquired A	8,150	$0.00	$0	8,150	Direct
08 Jun, 2026	Jane H Hollingsworth	Director	Acquired A	8,150	$0.00	$0	8,150	Direct
08 Jun, 2026	John J Alam	Ceo President	Acquired A	8,150	$0.00	$0	8,150	Indirect
11 Feb, 2026	William Robert Elder	Cfo, Gc Secretary	Acquired A	30,000	$0.00	$0	30,000	Direct
11 Feb, 2026	Matthew Winton	Chief Commercial And Business	Acquired A	30,000	$0.00	$0	30,000	Direct
11 Feb, 2026	Sylvie Gregoire	Director, TenPercentOwner	Acquired A	75,000	$0.00	$0	75,000	Indirect
11 Feb, 2026	Kelly Blackburn	Evp, Clinical Development	Acquired A	30,000	$0.00	$0	30,000	Direct
11 Feb, 2026	John J Alam	Ceo President	Acquired A	75,000	$0.00	$0	75,000	Direct
11 Feb, 2026	Rosch Mark De	Evp, Ra And Ga And Pgm	Acquired A	30,000	$0.00	$0	30,000	Direct

Showing 1 to 20 of 313 transactions